<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142502</url>
  </required_header>
  <id_info>
    <org_study_id>MED-INT-19-350</org_study_id>
    <nct_id>NCT04142502</nct_id>
  </id_info>
  <brief_title>Comparison of the Effects of Dexmedetomidine and Propofol on the Cardiovascular Autonomic Nervous System During Spinal Anesthesia</brief_title>
  <acronym>ANS</acronym>
  <official_title>Comparison of the Effects of Dexmedetomidine and Propofol on the Cardiovascular Autonomic Nervous System During Spinal Anesthesia: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ilsung Pharmaceuticals CO.,LTD.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal anesthesia induces bradycardia and hypotnesion, because itself decreases
      parasympathetic activity and increases sympathetic activity. These imbalance of autonomic
      nervous system can be measured by heart rate variability. Propofol and dexmedetomidine, which
      are used for sedation during spinal anesthesia, also affect autonomic nervous system, but the
      exact effects are not well known. The purpose of this study is measuring the effects of
      propofol or dexmedetomidine on autonomic nervous system in spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal anesthesia induces bradycardia and hypotnesion, because itself decreases
      parasympathetic activity and increases sympathetic activity. These imbalance of autonomic
      nervous system can be measured by heart rate variability. Propofol and dexmedetomidine, which
      are used for sedation during spinal anesthesia, also affect autonomic nervous system but the
      exact effects are not well known. Moreoever, the effect of spinal anesthesia combined with
      sedation agent on autonomic nervous system has not been evaluated. The purpose of this study
      is measuring the effects of propofol or dexmedetomidine on autonomic nervous system in spinal
      anesthesia. The current study is prospective randomized pilot study. Patients are assigned to
      propofol group and dexmedetomidine group. Using electrocardiaogram analysis, the change of
      autonomic nervous system will be measured from preoperative to end of surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Propofol group: propofol infusion as sedation drug Dexmedetomidine group: dexmedetomidine infusion as sedation drug</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serial heart rate variability</measure>
    <time_frame>40 minutes (before entering the operating room ~ 20 minutes after starting sedation</time_frame>
    <description>Serial change of frequency domain results from EKG RR interval Baseline: before entering the operating room T0: Preinduction T1: 10 minutes after spinal anesthesia T2: 10 minutes after starting sedation T3: 20 minutes after starting sedationi
Frequency domain results Total power (ms2) Low frequency (ms2) High frequency (ms2) LF/HF ratio</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spinal Anesthesia</condition>
  <condition>Autonomic Nervous System</condition>
  <arm_group>
    <arm_group_label>Propofol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using propofol as a sedation drug Infusion rate control Effect site concentration 0.3~1.0 mg/ml using target concentration infusion Bispectral index 60~80</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using dexmedetomidine as a sedation drug First 10 minutes 1.0 mcg/kg loading After 10 minutes 0.3-1.0 mcg/kg/hr maintenance Bispectral index 60~80</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol as a sedation drug</description>
    <arm_group_label>Propofol group</arm_group_label>
    <other_name>FRESofol MCT inj 1% 500mg/50ml, Fresenium Kabi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidin</intervention_name>
    <description>Dexmedetomidine as a sedation drug</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <other_name>Medex inj, 200mcg/2ml, ILSUNG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 20~60 years old

          -  Scheduled lower extremity surgery under spinal anesthesia

        Exclusion Criteria:

          -  Arryhthmia

          -  Uncooperative patients

          -  Diabetes

          -  On medication: beta blocker, psychiatric medicine

          -  Thyroid function abnormality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In Kyong Yi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>In Kyong Yi, MD</last_name>
    <phone>+82-31-219-7522</phone>
    <email>lyrin01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Han Bum Joe, MD</last_name>
    <phone>+82-31-219-4916</phone>
    <email>joehanbum@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ajou university school of medicine</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In Kyong Yi, MD</last_name>
      <phone>+82-10-3012-6972</phone>
      <email>lyrin01@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yoon Jung Chae, MD</last_name>
      <phone>+82-31-219-5689</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>In-kyong Yi</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia</keyword>
  <keyword>autonomic nervous system</keyword>
  <keyword>dexmedetomidine</keyword>
  <keyword>propofol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>If a reasonable personal request exist, the investigators can share the data personally.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

